Radiation Therapy Clinical Trials

16 recruiting

Radiation Therapy Trials at a Glance

45 actively recruiting trials for radiation therapy are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 20 trials, with the heaviest enrollment activity in Beijing, Shanghai, and Columbus. Lead sponsors running radiation therapy studies include Peking University First Hospital, Fudan University, and Affidea Nu-med Center of Oncological DIagnostics and Therapy.

Browse radiation therapy trials by phase

Treatments under study

About Radiation Therapy Clinical Trials

Looking for clinical trials for Radiation Therapy? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Radiation Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Radiation Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 45 trials

Recruiting
Not Applicable

A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer

Breast CancerRadiation Therapy Patient
Ohio State University Comprehensive Cancer Center55 enrolled1 locationNCT07447700
Recruiting
Not Applicable

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

Cervical CancerRadiation Therapy ComplicationPelvic Floor Disorders
University of Cincinnati28 enrolled1 locationNCT07447895
Recruiting
Not Applicable

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Metastatic SarcomaEwing SarcomaRhabdomyosarcoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins70 enrolled2 locationsNCT06796543
Recruiting
Not Applicable

CAIX PET/ CT Guided Radiation Therapy in CcRCC.

Metastatic Renal CancerRadiation TherapyRecurrent Renal Cell Cancer
Peking University First Hospital70 enrolled1 locationNCT07540260
Recruiting

Proton Therapy Patient Registry

Treatment With Proton Beam Radiation Therapy
Case Comprehensive Cancer Center999 enrolled1 locationNCT02986048
Recruiting
Phase 2Phase 3

PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer

Prostate CancerBrachytherapyStereotactic Body Radiation Therapy (SBRT)+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy1,600 enrolled1 locationNCT07426094
Recruiting
Phase 2Phase 3

PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer

Prostate Cancer (Adenocarcinoma)Stereotactic Body Radiation Therapy (SBRT)Localized Prostate Cancer+2 more
Affidea Nu-med Center of Oncological DIagnostics and Therapy1,200 enrolled1 locationNCT07426055
Recruiting
Phase 2

The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer

NSCLCImmunotherapyStereotactic Body Radiation Therapy (SBRT)
Fudan University27 enrolled1 locationNCT06738160
Recruiting

Ion Therapy Patient Registry

Ion Beam Radiation Therapy for Tumor Patients
EBG MedAustron GmbH2,800 enrolled1 locationNCT03049072
Recruiting
Not Applicable

Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy

Lung Cancer (NSCLC)Geriatric AssessmentStereotactic Body Radiation Therapy (SBRT)
Brigham and Women's Hospital64 enrolled1 locationNCT06987890
Recruiting
Not Applicable

EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)

Prostate CancerErectile Dysfunction Following Radiation Therapy
UMC Utrecht70 enrolled1 locationNCT04861194
Recruiting

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

Radiation Therapy
Memorial Sloan Kettering Cancer Center837 enrolled7 locationsNCT02422550
Recruiting
Not Applicable

Activity Coaching During Pelvic Radiation Therapy

Gynecologic CancerExercise TherapyRadiation Therapy
Inova Health Care Services16 enrolled4 locationsNCT06746428
Recruiting
Phase 3

Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors

Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm
University Health Network, Toronto148 enrolled1 locationNCT07444775
Recruiting
Not Applicable

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

Prostate Cancer MetastaticRadiation Therapy
Karin Soderkvist118 enrolled7 locationsNCT04983095
Recruiting
Phase 3

18F-FLUC PET/MR in Patients With Brain Mets

Brain MetastasisRadiation TherapyImmunotherapy, Active
University of Wisconsin, Madison30 enrolled1 locationNCT06159335
Recruiting

SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

Metastatic Renal CancerRadiation TherapyRecurrent Renal Cell Cancer
Peking University First Hospital300 enrolled2 locationsNCT06583070
Recruiting
Not Applicable

Locally Optimised Contouring With AI Technology for Radiotherapy

Artificial IntelligenceDeep LearningRadiation Therapy+2 more
Royal North Shore Hospital444 enrolled3 locationsNCT06546592
Recruiting
Not Applicable

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

Erectile DysfunctionErectile Dysfunction Following Radiation TherapyErectile Dysfunction Following Radical Prostatectomy+4 more
The Cleveland Clinic186 enrolled1 locationNCT05868668
Recruiting
Early Phase 1

Intraoral Hypothermia Device for Preserving Taste During Radiation

Head and Neck CancerRadiation TherapyTaste Dysfunction
Henry Ford Health System15 enrolled1 locationNCT06579248